Long-term study of large ceramic implants (porous hydroxyapatite) in dog femora. 1984

H A Hoogendoorn, and W Renooij, and L M Akkermans, and W Visser, and P Wittebol

Blocks of porous ceramic hydroxyapatite (dimensions, 2.5 X 1.25 X 0.5 cm; sintering temperature, 1300 degrees; macroporosity, 56%; average pore size 0.18 mm2) were implanted into surgically created defects in dog femora. The implants were retrieved up to 3.5 years after implantation. The implants were 3.5 years after implantation. The implants were firmly attached to the bone. Histologic evaluation suggests that optimal contact between bone and implant should be provided to accelerate bone ingrowth. Bone growth in the pores reached a maximum level after 35 weeks, at which time about one-third of the pore space was filled with bone. When measuring the relative surface areas of bone and ceramic on histologic slides, no change in ceramic mass could be detected, indicating that hydroxyapatite ceramics are not affected by biodegradation processes. The implants effectively provided a scaffold for bone growth bridging a larger bone defect.

UI MeSH Term Description Entries
D001846 Bone Development The growth and development of bones from fetus to adult. It includes two principal mechanisms of bone growth: growth in length of long bones at the epiphyseal cartilages and growth in thickness by depositing new bone (OSTEOGENESIS) with the actions of OSTEOBLASTS and OSTEOCLASTS. Bone Growth
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005269 Femur The longest and largest bone of the skeleton, it is situated between the hip and the knee. Trochanter,Greater Trochanter,Lesser Trochanter,Femurs,Greater Trochanters,Lesser Trochanters,Trochanter, Greater,Trochanter, Lesser,Trochanters,Trochanters, Greater,Trochanters, Lesser
D006882 Hydroxyapatites A group of compounds with the general formula M10(PO4)6(OH)2, where M is barium, strontium, or calcium. The compounds are the principal mineral in phosphorite deposits, biological tissue, human bones, and teeth. They are also used as an anticaking agent and polymer catalysts. (Grant & Hackh's Chemical Dictionary, 5th ed) Hydroxyapatite Derivatives,Derivatives, Hydroxyapatite
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D019736 Prostheses and Implants Artificial substitutes for body parts, and materials inserted into tissue for functional, cosmetic, or therapeutic purposes. Prostheses can be functional, as in the case of artificial arms and legs, or cosmetic, as in the case of an artificial eye. Implants, all surgically inserted or grafted into the body, tend to be used therapeutically. IMPLANTS, EXPERIMENTAL is available for those used experimentally. Implants, Artificial,Prostheses and Implant,Prosthesis,Prosthetic Implant,Endoprostheses,Endoprosthesis,Prostheses,Prosthetic Implants,Artificial Implant,Artificial Implants,Implant and Prostheses,Implant, Artificial,Implant, Prosthetic,Implants and Prostheses,Implants, Prosthetic

Related Publications

H A Hoogendoorn, and W Renooij, and L M Akkermans, and W Visser, and P Wittebol
July 2004, The Journal of bone and joint surgery. British volume,
H A Hoogendoorn, and W Renooij, and L M Akkermans, and W Visser, and P Wittebol
April 2001, Journal of biomedical materials research,
H A Hoogendoorn, and W Renooij, and L M Akkermans, and W Visser, and P Wittebol
November 1998, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons,
H A Hoogendoorn, and W Renooij, and L M Akkermans, and W Visser, and P Wittebol
May 1988, Zahnarztliche Mitteilungen,
H A Hoogendoorn, and W Renooij, and L M Akkermans, and W Visser, and P Wittebol
November 1960, Proceedings of the staff meetings. Mayo Clinic,
H A Hoogendoorn, and W Renooij, and L M Akkermans, and W Visser, and P Wittebol
August 1999, Plastic and reconstructive surgery,
H A Hoogendoorn, and W Renooij, and L M Akkermans, and W Visser, and P Wittebol
September 1994, Scandinavian journal of plastic and reconstructive surgery and hand surgery,
H A Hoogendoorn, and W Renooij, and L M Akkermans, and W Visser, and P Wittebol
February 1986, No shinkei geka. Neurological surgery,
H A Hoogendoorn, and W Renooij, and L M Akkermans, and W Visser, and P Wittebol
January 2006, Journal of long-term effects of medical implants,
H A Hoogendoorn, and W Renooij, and L M Akkermans, and W Visser, and P Wittebol
January 1997, Implant dentistry,
Copied contents to your clipboard!